Literature DB >> 29278853

LncRNA HIF1A-AS2 positively affects the progression and EMT formation of colorectal cancer through regulating miR-129-5p and DNMT3A.

Jinguan Lin1, Zhaohui Shi2, Zhiyuan Yu2, Zhe He2.   

Abstract

LncRNAs were a group of RNAs, which can be a regulator or master in biological activities of cancer cells. HIF1A-AS2 belongs to this group, and it has been verified to be able to affect cell activities in several kinds of cancers. In this study, we tried to study the functions of HIF1A-AS2 exerted in colorectal cancer. In order to clearly know about the expression of HIF1A-AS2, miR-129-5p and DNMT3A in CRC tissues and cells, we employed qRT-PCR. The relevance among those three genes was examined by the use of Pearson correlation analysis. With the aid of bioinformatics analysis and dual luciferase reporter assays, the combinations between them were verified one by one MTT, colony formation trans-well and western blotting, immunofluorescence, all those assays reflected a fact that as a ceRNA, HIF1A-AS2 could directly bind with miR-129-5p, and could positively affect cell proliferation, invasion and EMT formation by regulation of the expression of miR-129-5p and DNMT3A. Therefore, we obtained a conclusion that HIF1A-AS2 exerted the oncogenic functions in CRC through regulating miR-129-5p/DNMT3A axis, which indicates that HIF1A-AS2 might be a useful therapeutic target in CRC.
Copyright © 2017 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Colorectal cancer; DNMT3A; EMT; HIF1A-AS2; miR-129-5p

Mesh:

Substances:

Year:  2017        PMID: 29278853     DOI: 10.1016/j.biopha.2017.12.058

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  36 in total

Review 1.  Long non-coding RNAs and MYC association in hematological malignancies.

Authors:  Leonidas Benetatos; Agapi Benetatou; Georgios Vartholomatos
Journal:  Ann Hematol       Date:  2020-07-04       Impact factor: 3.673

2.  Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3.

Authors:  Alberto Puccini; Fotios Loupakis; Sebastian Stintzing; Shu Cao; Francesca Battaglin; Ryuma Togunaka; Madiha Naseem; Martin D Berger; Shivani Soni; Wu Zhang; Christoph Mancao; Bodour Salhia; Shannon M Mumenthaler; Daniel J Weisenberger; Gangning Liang; Chiara Cremolini; Volker Heinemann; Alfredo Falcone; Joshua Millstein; Heinz-Josef Lenz
Journal:  Eur J Cancer       Date:  2019-03-07       Impact factor: 9.162

3.  Knockdown of lncRNA HIF1A-AS2 increases drug sensitivity of SCLC cells in association with autophagy.

Authors:  Ebru Güçlü; Canan Eroğlu Güneş; Ercan Kurar; Hasibe Vural
Journal:  Med Oncol       Date:  2021-08-11       Impact factor: 3.064

4.  MiR-129-5p/TRIP13 affects malignant phenotypes of colorectal cancer cells.

Authors:  Yongqing Cao; Fang Huang; Jiheng Liu; Hui Qi; Jinjun Xiao
Journal:  Histol Histopathol       Date:  2022-04-01       Impact factor: 2.130

5.  [Silencing long non-coding RNA HIF1A-AS2 inhibits proliferation, invasion and migration of cervical cancer cells in vitro].

Authors:  Rong Deng; Fuyun Zhang; Fuzhen Lei; Wenjun Liu; Sisun Liu; Wenhua Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-11-30

6.  A developmental stage-specific network approach for studying dynamic co-regulation of transcription factors and microRNAs during craniofacial development.

Authors:  Fangfang Yan; Peilin Jia; Hiroki Yoshioka; Akiko Suzuki; Junichi Iwata; Zhongming Zhao
Journal:  Development       Date:  2020-12-24       Impact factor: 6.868

7.  LncRNA HIF1A-AS2 accelerates malignant phenotypes of renal carcinoma by modulating miR-30a-5p/SOX4 axis as a ceRNA.

Authors:  Mingwei Chen; Xuedong Wei; Xiu Shi; Le Lu; Guangbo Zhang; Yuhua Huang; Jianquan Hou
Journal:  Cancer Biol Med       Date:  2021-03-12       Impact factor: 4.248

Review 8.  Regulation of DNA methylation machinery by epi-miRNAs in human cancer: emerging new targets in cancer therapy.

Authors:  Mohammad Reza Karimzadeh; Peyman Pourdavoud; Naeim Ehtesham; Mohaddese Qadbeigi; Masood Movahedi Asl; Behrang Alani; Meysam Mosallaei; Bahram Pakzad
Journal:  Cancer Gene Ther       Date:  2020-08-10       Impact factor: 5.987

Review 9.  Role of microRNA-129 in cancer and non-cancerous diseases (Review).

Authors:  Bingpeng Deng; Xuan Tang; Yong Wang
Journal:  Exp Ther Med       Date:  2021-06-30       Impact factor: 2.447

10.  Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma.

Authors:  Yong Wang; Xiandong Zeng; Ningning Wang; Wei Zhao; Xi Zhang; Songling Teng; Yueyan Zhang; Zhi Lu
Journal:  Mol Cancer       Date:  2018-05-12       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.